Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
4 "Caregiver"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Letter to the editor
Knowledge, attitude and perception of genetic testing in patients with movement disorders, their caregivers and health care professionals
Sneha Kamath, Vikram V Holla, Nitish Kamble, Rohan R Mahale, Ravi Yadav, Pramod Kumar Pal
Received February 10, 2024  Accepted March 27, 2024  Published online March 27, 2024  
DOI: https://doi.org/10.14802/jmd.24034    [Accepted]
  • 278 View
  • 14 Download
PDF
Original Articles
Caregiver Burden of Patients With Huntington’s Disease in South Korea
Chan Young Lee, Chaewon Shin, Yun Su Hwang, Eungseok Oh, Manho Kim, Hyun Sook Kim, Sun Ju Chung, Young Hee Sung, Won Tae Yoon, Jin Whan Cho, Jae-Hyeok Lee, Han-Joon Kim, Hee Jin Chang, Beomseok Jeon, Kyung Ah Woo, Seong-Beom Koh, Kyum-Yil Kwon, Jangsup Moon, Young Eun Kim, Jee-Young Lee
J Mov Disord. 2024;17(1):30-37.   Published online September 11, 2023
DOI: https://doi.org/10.14802/jmd.23134
  • 1,905 View
  • 150 Download
  • 1 Comments
AbstractAbstract PDFSupplementary Material
Objective
This is the first prospective cohort study of Huntington’s disease (HD) in Korea. This study aimed to investigate the caregiver burden in relation to the characteristics of patients and caregivers.
Methods
From August 2020 to February 2022, we enrolled patients with HD from 13 university hospitals in Korea. We used the 12-item Zarit Burden Interview (ZBI-12) to evaluate the caregiver burden. We evaluated the clinical associations of the ZBI-12 scores by linear regression analysis and investigated the differences between the low- and high-burden groups.
Results
Sixty-five patients with HD and 45 caregivers were enrolled in this cohort study. The average age at onset of motor symptoms was 49.3 ± 12.3 years, with an average cytosine-adenine-guanine (CAG)n of 42.9 ± 4.0 (38–65). The median ZBI-12 score among our caregivers was 17.6 ± 14.2. A higher caregiver burden was associated with a more severe Shoulson–Fahn stage (p = 0.038) of the patients. A higher ZBI-12 score was also associated with lower independence scale (B = -0.154, p = 0.006) and functional capacity (B = -1.082, p = 0.002) scores of patients. The caregiving duration was longer in the high- than in the low-burden group. Caregivers’ demographics, blood relation, and marital and social status did not affect the burden significantly.
Conclusion
HD patients’ neurological status exerts an enormous impact on the caregiver burden regardless of the demographic or social status of the caregiver. This study emphasizes the need to establish an optimal support system for families dealing with HD in Korea. A future longitudinal analysis could help us understand how disease progression aggravates the caregiver burden throughout the entire disease course.
Health-Related Quality of Life for Parkinson’s Disease Patients and Their Caregivers
Michal Lubomski, Ryan L. Davis, Carolyn M. Sue
J Mov Disord. 2021;14(1):42-52.   Published online January 12, 2021
DOI: https://doi.org/10.14802/jmd.20079
  • 10,478 View
  • 287 Download
  • 25 Web of Science
  • 24 Crossref
AbstractAbstract PDF
Objective
Motor and non-motor symptoms (NMS) negatively impact the health-related quality of life (HRQoL) for individuals with Parkinson’s disease (PD), as well as their caregivers. NMS can emerge decades prior to the manifestation of motor symptoms but often go unrecognized and therefore untreated. To guide clinical management, we surveyed differences and identified factors that influence HRQoL in a cohort of PD patients and family caregivers.
Methods
A total of 103 PD patients were compared with 81 caregivers. Outcome measures collected from validated questionnaires included generic and disease-specific HRQoL assessments, depression frequency and severity, constipation severity, upper and lower gastrointestinal symptoms, physical activity and motor symptom severity.
Results
PD patients reported significantly decreased physical and mental HRQoL compared to their caregivers (both p < 0.001). Unemployment, the need for social support services, rehabilitation use, REM sleep behavior disorder, impulse control disorders and features suggestive of increasing disease severity hallmarked by increasing PD duration, higher MDS UPDRS-III (Movement Disorder Society–Unified Parkinson’s Disease Rating Scale–Part III) scores, higher daily levodopa equivalence dose and motor fluctuations were consistent with a lower HRQoL in our PD cohort. Furthermore, decreased physical activity, chronic pain, depression, constipation and upper gastrointestinal dysfunction (particularly indigestion, excess fullness and bloating) suggested vulnerability to reduced HRQoL. Overall, PD patients perceived their health to decline by 12% more than their caregivers did over a 1-year period.
Conclusion
PD patients reported decreased HRQoL, with both motor symptoms and NMS negatively impacting HRQoL. Our findings support the routine clinical screening of HRQoL in PD patients to identify and address modifiable factors.

Citations

Citations to this article as recorded by  
  • Risk factors and intervention of caregiver burden in Parkinson’s disease: a systematic review and meta-analysis
    Yan Zhao, Wenxiang Wu, Jianjun Wu, Bin Shen, Yanpei Cao, Yafang Xu
    Quality of Life Research.2024;[Epub]     CrossRef
  • Health-related quality of life in Parkinson’s disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores
    Raghu Bhanupriya, Madhumitha Haridoss, Goda Suchitra Lakshmi, Bhavani Shankara Bagepally
    Quality of Life Research.2024;[Epub]     CrossRef
  • Impact of advanced Parkinson’s disease on caregivers: an international real-world study
    Pablo Martinez-Martin, Matej Skorvanek, Tove Henriksen, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. Kandukuri, Vivek S. Chaudhari, Apeksha B. Patel, Juan Carlos Parra, James Pike, Angelo Antonini
    Journal of Neurology.2023; 270(4): 2162.     CrossRef
  • Perspectives of people with Parkinson's disease and family carers about disease management in community settings: A cross‐country qualitative study
    M. Victoria Navarta‐Sánchez, Ana Palmar‐Santos, Azucena Pedraz‐Marcos, Claire Reidy, Dia Soilemezi, Anita Haahr, Dorthe Sørensen, Helle Rønn Smidt, Line Kildal Bragstad, Ellen Gabrielsen Hjelle, Silje Bjørnsen Haavaag, Mari Carmen Portillo
    Journal of Clinical Nursing.2023; 32(15-16): 5201.     CrossRef
  • Barriers to home exercise for patients with Parkinson’s disease: a qualitative study
    Qiaohong Wang, Yiping Chen, Linbo Li, Chao Li, Li Li, Huili Cao, Hui Yang
    BMJ Open.2023; 13(2): e061932.     CrossRef
  • An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
    Hussaini Adam, Subash C. B. Gopinath, M. K. Md Arshad, Tijjani Adam, N. A. Parmin, Irzaman Husein, Uda Hashim
    3 Biotech.2023;[Epub]     CrossRef
  • Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem
    Ai Huey Tan, Kee Huat Chuah, Yuan Ye Beh, Jie Ping Schee, Sanjiv Mahadeva, Shen-Yang Lim
    Journal of Movement Disorders.2023; 16(2): 138.     CrossRef
  • Abdominal pain in Parkinson’s disease
    A.A. Pilipovich, O.V. Vorobyova, S.A. Makarov
    Russian Journal of Pain.2023; 21(2): 12.     CrossRef
  • The multifaceted impact of structured training program on persons with Parkinson disease and their adult caregiver: A protocol for a systematic review
    Sharmila Gopala Krishna Pillai, Nor Azlin Mohd Nordin, Norlinah Mohamed Ibrahim
    Medicine.2023; 102(28): e33966.     CrossRef
  • Detecting Minor Symptoms of Parkinson’s Disease in the Wild Using Bi-LSTM with Attention Mechanism
    Vasileios Skaramagkas, Iro Boura, Cleanthi Spanaki, Emilia Michou, Georgios Karamanis, Zinovia Kefalopoulou, Manolis Tsiknakis
    Sensors.2023; 23(18): 7850.     CrossRef
  • Lower gastrointestinal dysfunction in patients with Parkinson’s disease
    A.A. Pilipovich, O.V. Vorob’eva, S.A. Makarov, A.V. Kuchuk
    Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2023; 123(12): 42.     CrossRef
  • The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease
    Michal Lubomski, Xiangnan Xu, Andrew J. Holmes, Jean Y. H. Yang, Carolyn M. Sue, Ryan L. Davis
    Journal of Neurology.2022; 269(2): 780.     CrossRef
  • Predictive Model of Quality of Life in Patients with Parkinson’s Disease
    Eduardo Candel-Parra, María Pilar Córcoles-Jiménez, Victoria Delicado-Useros, Marta Carolina Ruiz-Grao, Antonio Hernández-Martínez, Milagros Molina-Alarcón
    International Journal of Environmental Research and Public Health.2022; 19(2): 672.     CrossRef
  • Die neue Parkinson-Schmerzklassifikation (PSK)
    V. Mylius, S. Perez Lloret, C. S. Brook, M. T. Krüger, S. Hägele-Link, R. Gonzenbach, J. Kassubek, S. Bohlhalter, J. P. Lefaucheur, L. Timmermann, G. Kägi, F. Brugger, D. Ciampi de Andrade, J. C. Möller
    Der Nervenarzt.2022; 93(10): 1019.     CrossRef
  • Quantification Analysis of Sleep Based on Smartwatch Sensors for Parkinson’s Disease
    Yi-Feng Ko, Pei-Hsin Kuo, Ching-Fu Wang, Yu-Jen Chen, Pei-Chi Chuang, Shih-Zhang Li, Bo-Wei Chen, Fu-Chi Yang, Yu-Chun Lo, Yi Yang, Shuan-Chu Vina Ro, Fu-Shan Jaw, Sheng-Huang Lin, You-Yin Chen
    Biosensors.2022; 12(2): 74.     CrossRef
  • Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage
    A. A. Pilipovich, O. V. Vorob’eva, S. A. Makarov, N. N. Shindryaeva, Yu D. Vorob’eva, Seyed-Mohammad Fereshtehnejad
    Parkinson's Disease.2022; 2022: 1.     CrossRef
  • Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
    Michal Lubomski, Xiangnan Xu, Andrew J. Holmes, Samuel Muller, Jean Y. H. Yang, Ryan L. Davis, Carolyn M. Sue
    Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
  • The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies
    Michal Lubomski, Xiangnan Xu, Andrew J. Holmes, Samuel Muller, Jean Y. H. Yang, Ryan L. Davis, Carolyn M. Sue
    Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
  • Characteristics and quality of life of substance users and their caregivers
    Jadranka M. Maksimovic, Olivera B. Sbutega, Aleksandar D. Pavlovic, Hristina D. Vlajinac, Ivana I. Kavecan, Isidora S. Vujcic, Sandra B. Grujicic Sipetic
    Medicine.2022; 101(31): e29699.     CrossRef
  • Defining the unknowns for cell therapies in Parkinson's disease
    Emma L. Lane, Mariah J. Lelos
    Disease Models & Mechanisms.2022;[Epub]     CrossRef
  • Increased Added Sugar Consumption Is Common in Parkinson's Disease
    Natalie C. Palavra, Michal Lubomski, Victoria M. Flood, Ryan L. Davis, Carolyn M. Sue
    Frontiers in Nutrition.2021;[Epub]     CrossRef
  • Relationship Satisfaction in People with Parkinson’s Disease and Their Caregivers: A Cross-Sectional Observational Study
    Johanne Heine, Hannah von Eichel, Selma Staege, Günter U. Höglinger, Florian Wegner, Martin Klietz
    Brain Sciences.2021; 11(6): 822.     CrossRef
  • Diagnosis and Management of Pain in Parkinson's Disease: A New Approach
    Veit Mylius, Jens Carsten Möller, Stephan Bohlhalter, Daniel Ciampi de Andrade, Santiago Perez Lloret
    Drugs & Aging.2021; 38(7): 559.     CrossRef
  • Cognitive Influences in Parkinson's Disease Patients and Their Caregivers: Perspectives From an Australian Cohort
    Michal Lubomski, Ryan L. Davis, Carolyn M. Sue
    Frontiers in Neurology.2021;[Epub]     CrossRef
Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are Associated with Increased Caregiver Burden
Yoon-Sang Oh, Ji E. Lee, Phil Hyu Lee, Joong-Seok Kim
J Mov Disord. 2015;8(1):26-32.   Published online January 31, 2015
DOI: https://doi.org/10.14802/jmd.14019
  • 20,880 View
  • 119 Download
  • 37 Web of Science
  • 34 Crossref
AbstractAbstract PDF
Objective Neuropsychiatric symptoms are common in Parkinson’s disease dementia (PDD). Frequent and severe neuropsychiatric symptoms create high levels of distress for patients and caregivers, decreasing their quality of life. The aim of this study was to investigate neuropsychiatric symptoms that may contribute to increased caregiver burden in PDD patients.
Methods Forty-eight PDD patients were assessed using the 12-item Neuropsychiatric Inventory (NPI) to determine the frequency and severity of mental and behavioral problems. The Burden Interview and Caregiver Burden Inventory were used to evaluate caregiver burden.
Results All but one patient showed one or more neuropsychiatric symptoms. The three most frequent neuropsychiatric symptoms were apathy (70.8%) and anxiety (70.8%), followed by depression (68.7%). More severe neuropsychiatric symptoms were significantly correlated with increased caregiver burden. The domains of delusion, hallucination, agitation and aggression, anxiety, irritability and lability, and aberrant motor behavior were associated with caregiver stress. After controlling for age and other potential confounding variables, total NPI score was significantly associated with caregiver burden.
Conclusions The results of this study confirm that neuropsychiatric symptoms are frequent and severe in patients with PDD and are associated with increased caregiver distress. A detailed evaluation and management of neuropsychiatric symptoms in PDD patients appears necessary to improve patient quality of life and reduce caregiver burden.

Citations

Citations to this article as recorded by  
  • Caregiver Burden of Patients With Huntington’s Disease in South Korea
    Chan Young Lee, Chaewon Shin, Yun Su Hwang, Eungseok Oh, Manho Kim, Hyun Sook Kim, Sun Ju Chung, Young Hee Sung, Won Tae Yoon, Jin Whan Cho, Jae-Hyeok Lee, Han-Joon Kim, Hee Jin Chang, Beomseok Jeon, Kyung Ah Woo, Seong-Beom Koh, Kyum-Yil Kwon, Jangsup Mo
    Journal of Movement Disorders.2024; 17(1): 30.     CrossRef
  • Impact of advanced Parkinson’s disease on caregivers: an international real-world study
    Pablo Martinez-Martin, Matej Skorvanek, Tove Henriksen, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. Kandukuri, Vivek S. Chaudhari, Apeksha B. Patel, Juan Carlos Parra, James Pike, Angelo Antonini
    Journal of Neurology.2023; 270(4): 2162.     CrossRef
  • Motor Complications and Treatment in Advanced Parkinson's Disease #456
    Caroline E. Olvera, Jori E. Fleisher, Neha M. Kramer
    Journal of Palliative Medicine.2023; 26(5): 730.     CrossRef
  • A single centre prospective study of three device-assisted therapies for Parkinson’s disease
    Hugo Morales-Briceño, Ainhi D. Ha, Han-Lin Chiang, Yicheng Tai, Florence C. F. Chang, David S. Tsui, Jane Griffith, Donna Galea, Samuel D. Kim, Belinda Cruse, Neil Mahant, Victor S. C. Fung
    npj Parkinson's Disease.2023;[Epub]     CrossRef
  • Unawareness of Apathy in Parkinson’s Disease: The Role of Executive Dysfunction on Symptom Recognition
    Gianpaolo Maggi, Carmine Vitale, Alessia Delle Curti, Marianna Amboni, Gabriella Santangelo
    Brain Sciences.2023; 13(6): 964.     CrossRef
  • Caregiver Burden in Late-Stage Parkinsonism and Its Associations
    Stefania Kalampokini, Adrianus L. A. J. Hommel, Stefan Lorenzl, Joaquim J. Ferreira, Wassilios G. Meissner, Per Odin, Bastiaan R. Bloem, Richard Dodel, Anette-Eleonore Schrag
    Journal of Geriatric Psychiatry and Neurology.2022; 35(1): 110.     CrossRef
  • Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries
    Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J. Soileau, Ramon Rodriguez-Cruz, Stuart H. Isaacson, Aristide Merola, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Juan Carlos Parra, Pavnit
    Neurology and Therapy.2022; 11(1): 303.     CrossRef
  • Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson’s Disease: A PMD Alliance Survey
    Neal Hermanowicz, Maria Cristina Ospina, Yasar Torres-Yaghi, Sherrie Gould, Kelly Papesh, Jason A Rivera, Susan Miller, Sarah Jones, Kelli Musick, Damian May
    Neuropsychiatric Disease and Treatment.2022; Volume 18: 633.     CrossRef
  • Exploring the experiences of living with Lewy body dementia: An integrative review
    Allison Bentley, Tessa Morgan, Yakubu Salifu, Catherine Walshe
    Journal of Advanced Nursing.2021; 77(12): 4632.     CrossRef
  • Neuropsychiatric symptoms in Parkinson’s disease: association with caregiver distress and disease severity
    Wan-Chen Tsai, Hui-Chen Lin, Chiung-Chih Chang, Wen-Neng Chang, Chih-Cheng Huang, Kuei-Yueh Cheng, Hung-Chen Wang, Wei-Che Lin, Sheng-Yuan Hsiao, Yun-Ru Lai, Cheng-Hsien Lu, Nai-Wen Tsai
    International Psychogeriatrics.2020; 32(6): 733.     CrossRef
  • Caregiver Burden, Quality of Life and Related Factors in Family Caregivers of Dementia Patients in Turkey
    Zeliha Tulek, Dilek Baykal, Sumeyye Erturk, Basar Bilgic, Hasmet Hanagasi, I. Hakan Gurvit
    Issues in Mental Health Nursing.2020; 41(8): 741.     CrossRef
  • Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice
    Claudia Lazcano-Ocampo, Yi Min Wan, Daniel J van Wamelen, Lucia Batzu, Iro Boura, Nataliya Titova, Valentina Leta, Mubasher Qamar, Pablo Martinez-Martin, K Ray Chaudhuri
    Expert Review of Neurotherapeutics.2020; 20(5): 477.     CrossRef
  • A systematic review of the association between individual behavioural and psychological symptoms in dementia and carer burden
    Catriona George, Nuno Ferreira, Rosalind Evans, Victoria Honeyman
    Working with Older People.2020; 24(3): 181.     CrossRef
  • Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden


    Nicola Modugno, Angelo Antonini, Alessandro Tessitore, Pietro Marano, Francesco Ernesto Pontieri, Nicola Tambasco, Margherita Canesi, Giovanni Fabbrini, Mariachiara Sensi, Rocco Quatrale, Paolo Solla, Giovanni Defazio, Gabriella Melzi, Giuliana Gualberti,
    Neuropsychiatric Disease and Treatment.2020; Volume 16: 2899.     CrossRef
  • A Comparative Study of the Behavioral Profile of the Behavioral Variant of Frontotemporal Dementia and Parkinson’s Disease Dementia
    Dinesh Saini, Adreesh Mukherjee, Arijit Roy, Atanu Biswas
    Dementia and Geriatric Cognitive Disorders Extra.2020; 10(3): 182.     CrossRef
  • The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States
    Pablo Martinez‐Martin, Dendy Macaulay, Yash J. Jalundhwala, Fan Mu, Erika Ohashi, Thomas Marshall, Kavita Sail
    Movement Disorders.2019; 34(2): 236.     CrossRef
  • The association between specific neuropsychiatric disturbances in people with Alzheimer's disease and dementia with Lewy bodies and carer distress
    Toril Marie Terum, Ingelin Testad, Arvid Rongve, Dag Aarsland, Ellen Svendsboe, John Roger Andersen
    International Journal of Geriatric Psychiatry.2019; 34(10): 1421.     CrossRef
  • Trait Impulsivity Is Independent of Mild Cognitive Impairment in a Parkinson’s Disease Cohort
    Ashani Jeyadevan, Megan C. Bakeberg, Michelle Byrnes, Jade Kenna, Soumya Ghosh, Rick Stell, Sue Walters, Tess Evans, Sarah McGregor, Malcolm Horne, Frank L. Mastaglia, Ryan S. Anderton
    Parkinson's Disease.2019; 2019: 1.     CrossRef
  • Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study
    Alessandro Tessitore, Pietro Marano, Nicola Modugno, Francesco E. Pontieri, Nicola Tambasco, Margherita Canesi, Anna Latorre, Leonardo Lopiano, Mariachiara Sensi, Rocco Quatrale, Paolo Solla, Giovanni Defazio, Gabriella Melzi, Anna Maria Costanzo, Giulian
    Journal of Neurology.2018; 265(5): 1124.     CrossRef
  • Estudio observacional transversal de la sobrecarga en cuidadoras informales y los determinantes relacionados con la atención a las personas dependientes
    Ana María Rodríguez-González, Eva Rodríguez-Míguez, Ana Duarte-Pérez, Eduardo Díaz-Sanisidro, Ángel Barbosa-Álvarez, Ana Clavería
    Atención Primaria.2017; 49(3): 156.     CrossRef
  • Cognitive impairment in Parkinson's disease: impact on quality of life of carers
    RA Lawson, AJ Yarnall, F Johnston, GW Duncan, TK Khoo, D Collerton, JP Taylor, DJ Burn
    International Journal of Geriatric Psychiatry.2017; 32(12): 1362.     CrossRef
  • Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle
    Rita Moretti, Paola Caruso, Matteo Dal Ben
    Parkinson's Disease.2017; 2017: 1.     CrossRef
  • The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review
    Toril Marie Terum, John Roger Andersen, Arvid Rongve, Dag Aarsland, Ellen J. Svendsboe, Ingelin Testad
    International Journal of Geriatric Psychiatry.2017; 32(7): 703.     CrossRef
  • Neuropsychiatric symptoms in Alzheimer’s disease: associations with caregiver burden and treatment outcomes
    C.T. Chen, C.-C. Chang, W.-N. Chang, N.-W. Tsai, C.-C. Huang, Y.-T. Chang, H.-C. Wang, C.-T. Kung, Y.-J. Su, W.-C. Lin, B.-C. Cheng, C.-M. Su, S.-Y. Hsiao, C.-W. Hsu, C.-H. Lu
    QJM: An International Journal of Medicine.2017; 110(9): 565.     CrossRef
  • Hallucinations in Healthy Older Adults: An Overview of the Literature and Perspectives for Future Research
    Johanna C. Badcock, Hedwige Dehon, Frank Larøi
    Frontiers in Psychology.2017;[Epub]     CrossRef
  • Dementia Caregiver Burden: a Research Update and Critical Analysis
    Sheung-Tak Cheng
    Current Psychiatry Reports.2017;[Epub]     CrossRef
  • Patients and Their Caregivers’ Burdens for Parkinson’s Disease in Korea
    Jong Sam Baik, Joong-Seok Kim, Seong-Beom Koh, Jin Whan Cho, Phil Hyu Lee, Hyeo-Il Ma, Yun Joong Kim, Tae-Beom Ahn, Sang Jin Kim, Yong Duk Kim, Seong-min Choi, Ho-Won Lee, Hee Tae Kim
    Journal of Movement Disorders.2017; 10(3): 109.     CrossRef
  • Prevalence and treatment pattern of Parkinson's disease dementia in Korea
    Yoon‐Sang Oh, Joong‐Seok Kim, In‐Seok Park, Yong‐Soo Shim, In‐Uk Song, Jeong‐Wook Park, Phil‐Hyu Lee, Chul‐Hyung Lyoo, Tae‐Beom Ahn, Hyo‐Il Ma, Yong‐Duk Kim, Seong‐Beom Koh, Seung‐Jae Lee, Kwang‐Soo Lee
    Geriatrics & Gerontology International.2016; 16(2): 230.     CrossRef
  • Genetic architecture for human aggression: A study of gene–phenotype relationship in OMIM
    Yanli Zhang‐James, Stephen V. Faraone
    American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.2016; 171(5): 641.     CrossRef
  • The relationship between specific cognitive defects and burden of care in Parkinson's disease
    Michael Zhong, Richard Peppard, Dennis Velakoulis, Andrew H. Evans
    International Psychogeriatrics.2016; 28(2): 275.     CrossRef
  • Effect of lumbo-peritoneal shunt surgery on neuropsychiatric symptoms in patients with idiopathic normal pressure hydrocephalus
    Hideki Kanemoto, Hiroaki Kazui, Yukiko Suzuki, Syunsuke Sato, Haruhiko Kishima, Toshiki Yoshimine, Kenji Yoshiyama
    Journal of the Neurological Sciences.2016; 361: 206.     CrossRef
  • The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson’s disease
    Stefan Hermanowicz, Neal Hermanowicz
    Expert Review of Neurotherapeutics.2016; 16(6): 625.     CrossRef
  • Neuropsychiatric symptoms in Serbian patients with Parkinson's disease
    Mirjana Petrovic, Elka Stefanova, Ljubomir Ziropadja, Tanja Stojkovic, Vladimir S. Kostic
    Journal of the Neurological Sciences.2016; 367: 342.     CrossRef
  • Managing cognition in progressive supranuclear palsy
    Timothy Rittman, Ian TS Coyle-Gilchrist, James B Rowe
    Neurodegenerative Disease Management.2016; 6(6): 499.     CrossRef

JMD : Journal of Movement Disorders